Information PortalData Portal

Data Matrix

Tools & Workflows

Documentation

Myelin-associated glycoprotein (Protein)

Description: A protein in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Myelin-associated glycoprotein 's neighborhood in the knowledge graph.

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

Report a bug

Data & Metadata

Tools & Use Cases

@CFDE Workbench 2024

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Data & Metadata

Tools & Use Cases

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2024

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
	sodium(2R,4S,5R,6R)-5-acetamido-2-(((2R,3R,4R,5R,6S)-5-acetamido-6-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-3-hydroxy-4-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yl)methoxy)-6-((1R,2R)-3-(4-chlorobenzamido)-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50
	sodium(2R,4S,5R,6R)-6-((1R,2R)-3-benzamido-1,2-dihydroxypropyl)-2-(2,3-difluorobenzyloxy)-5-(2-fluoroacetamido)-4-hydroxytetrahydro-2H-pyran-2-carboxylate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	Kd
	sodium(2R,4S,5R,6R)-5-acetamido-2-(((2R,3R,4R,5R,6S)-5-acetamido-4-((2R,3R,4S,5S,6R)-4-((2S,4S,5R,6R)-5-acetamido-2-carboxylato-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-6-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-3-hydroxytetrahydro-2H-pyran-2-yl)methoxy)-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50
	O3-[(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulo-pyranosylonic acid)-(2->3)-beta-Dgalactopyranosyl-(1->3)-[5-acetamido-9-p-fluoro-benzoylamido-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulo-pyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-alpha-D-galactopyranosyl]-N-acetamido-L-threonine methyl ester sodium salt Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50
	sodium(2S,4S,5R,6R)-5-acetamido-2-((2R,3R,4S,5S,6R)-2-((2S,3R,4R,5R,6R)-3-acetamido-2-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-6-((1R,2R)-3-benzamido-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50
	Myelin-associated glycoprotein Protein (Entity type)	Has isoform Knowledge Graph Relation (Entity type)	UNIPROTKB.ISOFORM:P20916-1 CUI Isoform (Entity type)
	sodium(2S,4S,5R,6R)-5-acetamido-2-((2R,3R,4S,5S,6R)-2-((2S,3R,4R,5R,6R)-3-acetamido-2-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-6-((1R,2R)-3-(4-fluorobenzamido)-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50
	O3-[(5-acetamido-9-p-fluoro-benzoylamido-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosylonic acid)-(2->3)-beta-D-galactopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulo-pyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-alpha-D-galactopyranosyl]-N-acetamido-L-threonine methyl ester sodium salt Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50
	(2R,4S,5R,6R)-5-acetamido-2-(((2R,3R,4R,5R,6S)-5-acetamido-4-((2R,3R,4S,5S,6R)-4-((2S,4S,5R,6R)-5-acetamido-2-carboxylato-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-6-((1S,2R)-1-amino-1-carboxypropan-2-yloxy)-3-hydroxytetrahydro-2H-pyran-2-yl)methoxy)-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50
	sodium(2S,4S,5R,6R)-5-acetamido-2-((2R,3R,4S,5S,6R)-2-((2S,3R,4R,5R,6R)-3-acetamido-2-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-6-((1R,2R)-3-(4-chlorobenzamido)-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Myelin-associated glycoprotein Protein (Entity type)	IC50

sodium(2R,4S,5R,6R)-5-acetamido-2-(((2R,3R,4R,5R,6S)-5-acetamido-6-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-3-hydroxy-4-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)tetrahydro-2H-pyran-2-yl)methoxy)-6-((1R,2R)-3-(4-chlorobenzamido)-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

sodium(2R,4S,5R,6R)-6-((1R,2R)-3-benzamido-1,2-dihydroxypropyl)-2-(2,3-difluorobenzyloxy)-5-(2-fluoroacetamido)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
Kd

sodium(2R,4S,5R,6R)-5-acetamido-2-(((2R,3R,4R,5R,6S)-5-acetamido-4-((2R,3R,4S,5S,6R)-4-((2S,4S,5R,6R)-5-acetamido-2-carboxylato-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-6-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-3-hydroxytetrahydro-2H-pyran-2-yl)methoxy)-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

O3-[(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulo-pyranosylonic acid)-(2->3)-beta-Dgalactopyranosyl-(1->3)-[5-acetamido-9-p-fluoro-benzoylamido-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulo-pyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-alpha-D-galactopyranosyl]-N-acetamido-L-threonine methyl ester sodium salt
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

sodium(2S,4S,5R,6R)-5-acetamido-2-((2R,3R,4S,5S,6R)-2-((2S,3R,4R,5R,6R)-3-acetamido-2-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-6-((1R,2R)-3-benzamido-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

Myelin-associated glycoprotein
Protein (Entity type)
Has isoform
Knowledge Graph Relation (Entity type)
UNIPROTKB.ISOFORM:P20916-1 CUI
Isoform (Entity type)

sodium(2S,4S,5R,6R)-5-acetamido-2-((2R,3R,4S,5S,6R)-2-((2S,3R,4R,5R,6R)-3-acetamido-2-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-6-((1R,2R)-3-(4-fluorobenzamido)-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

O3-[(5-acetamido-9-p-fluoro-benzoylamido-3,5,9-trideoxy-D-glycero-alpha-D-galacto-2-nonulopyranosylonic acid)-(2->3)-beta-D-galactopyranosyl-(1->3)-[5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-2-nonulo-pyranosylonic acid-(2->6)]-2-acetamido-2-deoxy-alpha-D-galactopyranosyl]-N-acetamido-L-threonine methyl ester sodium salt
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

(2R,4S,5R,6R)-5-acetamido-2-(((2R,3R,4R,5R,6S)-5-acetamido-4-((2R,3R,4S,5S,6R)-4-((2S,4S,5R,6R)-5-acetamido-2-carboxylato-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-6-((1S,2R)-1-amino-1-carboxypropan-2-yloxy)-3-hydroxytetrahydro-2H-pyran-2-yl)methoxy)-4-hydroxy-6-((1R,2R)-1,2,3-trihydroxypropyl)tetrahydro-2H-pyran-2-carboxylate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

sodium(2S,4S,5R,6R)-5-acetamido-2-((2R,3R,4S,5S,6R)-2-((2S,3R,4R,5R,6R)-3-acetamido-2-((2R,3S)-3-acetamido-4-methoxy-4-oxobutan-2-yloxy)-5-hydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yloxy)-6-((1R,2R)-3-(4-chlorobenzamido)-1,2-dihydroxypropyl)-4-hydroxytetrahydro-2H-pyran-2-carboxylate
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Myelin-associated glycoprotein
Protein (Entity type)
IC50

DISPLAY PER PAGE